Search Results

Site Search

MCL @Work: Jessica Balcom - Insights

In 2010, Jessica Balcom began her career with Mayo Clinic supporting molecular testing in the Department of Laboratory Medicine and Pathology with a joint appointment in the Mayo Clinic Cystic Fibrosis Center. Now she serves as a...

Mayo Clinic Staff Members Honored in ASCP's "40 under Forty" - Insights

The American Society for Clinical Pathology (ASCP) has announced the 2017 “40 under Forty” honorees. Each year, the Selection Committee identifies 40 ASCP members under the age of 40 who are recognized for being future pathology and...

Communique - Insights

Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.

Present Approaches to Testing - Insights

Discussing current test applications that you can implement in your laboratory or practice today.

Frequently asked questions - Insights

Check out how chromosomal microarray testing at Mayo Clinic Laboratories can help optimize treatment for neurological tumors.

Neuro-Oncology Testing - Mayo Clinic Laboratories

At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient

Hereditary Alzheimer's disease and dementia - Insights

Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.

Future Direction of Lab Medicine - Insights

Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.

Other - Insights

The following on demand education is related to the “Other” category in medical laboratory science (MLS), which encompasses a variety of specialized topics and emerging areas that don’t fall into traditional categories like hematology,...

A novel testing approach for newly identified VEXAS syndrome - Insights

VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...